Cargando…
Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis
Primary Sjögren’s Syndrome (pSS) is a systemic autoimmune disease that primarily attacks the lacrimal and salivary glands, resulting in impaired secretory function characterized by xerostomia and xerophthalmia. Patients with pSS have been shown to have impaired salivary gland innervation and altered...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216552/ https://www.ncbi.nlm.nih.gov/pubmed/37408182 http://dx.doi.org/10.3390/cells12101347 |
_version_ | 1785048326066929664 |
---|---|
author | Rosso, Pamela Fico, Elena Colafrancesco, Serena Bellizzi, Mario Giuseppe Priori, Roberta Cerbelli, Bruna Leopizzi, Martina Giordano, Carla Greco, Antonio Tirassa, Paola Severini, Cinzia Fusconi, Massimo |
author_facet | Rosso, Pamela Fico, Elena Colafrancesco, Serena Bellizzi, Mario Giuseppe Priori, Roberta Cerbelli, Bruna Leopizzi, Martina Giordano, Carla Greco, Antonio Tirassa, Paola Severini, Cinzia Fusconi, Massimo |
author_sort | Rosso, Pamela |
collection | PubMed |
description | Primary Sjögren’s Syndrome (pSS) is a systemic autoimmune disease that primarily attacks the lacrimal and salivary glands, resulting in impaired secretory function characterized by xerostomia and xerophthalmia. Patients with pSS have been shown to have impaired salivary gland innervation and altered circulating levels of neuropeptides thought to be a cause of decreased salivation, including substance P (SP). Using Western blot analysis and immunofluorescence studies, we examined the expression levels of SP and its preferred G protein-coupled TK Receptor 1 (NK1R) and apoptosis markers in biopsies of the minor salivary gland (MSG) from pSS patients compared with patients with idiopathic sicca syndrome. We confirmed a quantitative decrease in the amount of SP in the MSG of pSS patients and demonstrated a significant increase in NK1R levels compared with sicca subjects, indicating the involvement of SP fibers and NK1R in the impaired salivary secretion observed in pSS patients. Moreover, the increase in apoptosis (PARP-1 cleavage) in pSS patients was shown to be related to JNK phosphorylation. Since there is no satisfactory therapy for the treatment of secretory hypofunction in pSS patients, the SP pathway may be a new potential diagnostic tool or therapeutic target. |
format | Online Article Text |
id | pubmed-10216552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102165522023-05-27 Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis Rosso, Pamela Fico, Elena Colafrancesco, Serena Bellizzi, Mario Giuseppe Priori, Roberta Cerbelli, Bruna Leopizzi, Martina Giordano, Carla Greco, Antonio Tirassa, Paola Severini, Cinzia Fusconi, Massimo Cells Communication Primary Sjögren’s Syndrome (pSS) is a systemic autoimmune disease that primarily attacks the lacrimal and salivary glands, resulting in impaired secretory function characterized by xerostomia and xerophthalmia. Patients with pSS have been shown to have impaired salivary gland innervation and altered circulating levels of neuropeptides thought to be a cause of decreased salivation, including substance P (SP). Using Western blot analysis and immunofluorescence studies, we examined the expression levels of SP and its preferred G protein-coupled TK Receptor 1 (NK1R) and apoptosis markers in biopsies of the minor salivary gland (MSG) from pSS patients compared with patients with idiopathic sicca syndrome. We confirmed a quantitative decrease in the amount of SP in the MSG of pSS patients and demonstrated a significant increase in NK1R levels compared with sicca subjects, indicating the involvement of SP fibers and NK1R in the impaired salivary secretion observed in pSS patients. Moreover, the increase in apoptosis (PARP-1 cleavage) in pSS patients was shown to be related to JNK phosphorylation. Since there is no satisfactory therapy for the treatment of secretory hypofunction in pSS patients, the SP pathway may be a new potential diagnostic tool or therapeutic target. MDPI 2023-05-09 /pmc/articles/PMC10216552/ /pubmed/37408182 http://dx.doi.org/10.3390/cells12101347 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Rosso, Pamela Fico, Elena Colafrancesco, Serena Bellizzi, Mario Giuseppe Priori, Roberta Cerbelli, Bruna Leopizzi, Martina Giordano, Carla Greco, Antonio Tirassa, Paola Severini, Cinzia Fusconi, Massimo Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis |
title | Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis |
title_full | Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis |
title_fullStr | Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis |
title_full_unstemmed | Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis |
title_short | Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren’s Syndrome (pSS) Pathogenesis |
title_sort | involvement of substance p (sp) and its related nk1 receptor in primary sjögren’s syndrome (pss) pathogenesis |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216552/ https://www.ncbi.nlm.nih.gov/pubmed/37408182 http://dx.doi.org/10.3390/cells12101347 |
work_keys_str_mv | AT rossopamela involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT ficoelena involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT colafrancescoserena involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT bellizzimariogiuseppe involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT prioriroberta involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT cerbellibruna involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT leopizzimartina involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT giordanocarla involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT grecoantonio involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT tirassapaola involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT severinicinzia involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis AT fusconimassimo involvementofsubstancepspanditsrelatednk1receptorinprimarysjogrenssyndromepsspathogenesis |